Hearing and vision rehabilitation for people with dementia in five European countries (SENSE-Cog): a randomised controlled trial
Iracema Leroi(Trinity College Dublin), Éric Frison(Université de Bordeaux), Mark Hann(Manchester Academic Health Science Centre), Emma Hooper(University of Manchester), Christopher J. Armitage(Manchester Academic Health Science Centre), Wai Kent Yeung(University of Manchester), Elizabeth Camacho(Manchester Academic Health Science Centre), Anna Pavlina Charalambous(European University Cyprus), Rachel Elliott(University of Nottingham), Alison Holden(Lancashire Care NHS Foundation Trust), Chryssoula Thodi(European University Cyprus), Fofi Constantinidou, Luke Paterson(University of Manchester), Brian Lawlor(Trinity College Dublin), Renaud David(Centre Hospitalier Universitaire de Nice), Seán Kennelly(Trinity College Dublin), Julie Longobardi(Université de Bordeaux), Evangelia Kontogianni(National and Kapodistrian University of Athens), David Reeves(University of Manchester), J. P. Connelly(Trinity College Dublin), Christine Schwimmer(Université de Bordeaux), Mark Worthington(Lancashire Care NHS Foundation Trust), Antonis Politis(National and Kapodistrian University of Athens), Piers Dawes(The University of Queensland)
Cited by 16
Related Papers
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|Nature Genetics|2011|2.1k
The “online brain”: how the Internet may be changing our cognition
|World Psychiatry|2019|628